Correlation Between Ventyx Biosciences and Kalvista Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ventyx Biosciences and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ventyx Biosciences and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ventyx Biosciences and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on Ventyx Biosciences and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ventyx Biosciences with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ventyx Biosciences and Kalvista Pharmaceuticals.
Diversification Opportunities for Ventyx Biosciences and Kalvista Pharmaceuticals
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Ventyx and Kalvista is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Ventyx Biosciences and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and Ventyx Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ventyx Biosciences are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of Ventyx Biosciences i.e., Ventyx Biosciences and Kalvista Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ventyx Biosciences and Kalvista Pharmaceuticals
Given the investment horizon of 90 days Ventyx Biosciences is expected to generate 1.68 times more return on investment than Kalvista Pharmaceuticals. However, Ventyx Biosciences is 1.68 times more volatile than Kalvista Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Kalvista Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 216.00 in Ventyx Biosciences on September 1, 2024 and sell it today you would earn a total of 52.00 from holding Ventyx Biosciences or generate 24.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ventyx Biosciences vs. Kalvista Pharmaceuticals
Performance |
| Timeline |
| Ventyx Biosciences |
| Kalvista Pharmaceuticals |
Ventyx Biosciences and Kalvista Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ventyx Biosciences and Kalvista Pharmaceuticals
The main advantage of trading using opposite Ventyx Biosciences and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ventyx Biosciences position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.| Ventyx Biosciences vs. Crinetics Pharmaceuticals | Ventyx Biosciences vs. Enanta Pharmaceuticals | Ventyx Biosciences vs. Amicus Therapeutics | Ventyx Biosciences vs. Connect Biopharma Holdings |
| Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | Kalvista Pharmaceuticals vs. Kura Oncology | Kalvista Pharmaceuticals vs. Viridian Therapeutics | Kalvista Pharmaceuticals vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |